D ercole syndrome

From WikiMD's WELLNESSPEDIA

D'Ercole Syndrome, also known as Fetal Growth Restriction (FGR) or Intrauterine Growth Restriction (IUGR), is a condition characterized by a fetus not reaching its genetically determined potential size. This medical condition can have significant implications for the health and development of the affected infant both before and after birth. Understanding D'Ercole Syndrome requires an exploration of its causes, diagnosis, treatment options, and potential outcomes for affected individuals.

Causes[edit]

The causes of D'Ercole Syndrome are multifactorial and can be broadly categorized into maternal, fetal, and placental factors. Maternal factors include conditions such as malnutrition, anemia, and pre-existing chronic diseases like diabetes and hypertension. Fetal factors might involve genetic abnormalities or infections. Placental factors refer to issues with the placenta itself, such as placental insufficiency, which leads to inadequate nutrient and oxygen delivery to the fetus.

Diagnosis[edit]

Diagnosis of D'Ercole Syndrome typically involves a combination of ultrasound measurements and maternal serum screening tests. Ultrasound can assess fetal size, amniotic fluid volume, and placental function, while maternal blood tests can help identify biomarkers indicative of placental insufficiency. In some cases, additional tests such as Doppler ultrasound may be used to evaluate blood flow in the umbilical artery, providing further insight into the health of the placenta and fetus.

Treatment[edit]

Treatment for D'Ercole Syndrome aims to improve fetal growth and prevent complications. Management strategies depend on the severity of the growth restriction and the gestational age of the fetus. In mild cases, increased maternal nutrition and monitoring may be sufficient. In more severe cases, hospitalization and closer monitoring of the fetus may be necessary. In critical situations, early delivery may be considered to prevent stillbirth or significant neonatal complications.

Outcomes[edit]

The outcomes for infants with D'Ercole Syndrome vary widely. Some infants may catch up in growth after birth, while others may experience long-term health and developmental issues. Complications can include neurological disorders, cardiovascular problems, and metabolic syndromes. Early intervention and supportive care can improve the prognosis for many affected infants.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.